This day-long event is designed for scientists, health professionals and stakeholders from academia and industry involved in the development of novel therapeutics for neurological indications and offers a unique opportunity to connect with and learn from an international group of scientists.
The symposium is a satellite event of the American Society for Human Genetics Annual Meeting (October 20-24) in Montreal, and takes place the day before the start of ASHG proceedings.
Event information
Date: Monday, October 19, 2026
Sessions: 9am to 4:30pm
Networking cocktail: 4:30pm to 6pm
Location: Le Centre Sheraton
1201 boul. René-Lévesque Ouest
Montréal, Québec, H3B 2L7
Métro: Bonaventure
Platinum
Sponsors- Logo featured across all print and digital material
- Ad in symposium print material
- 4 complimentary event registrations
- Logo on sponsors’ recognition banner in registration area
- Exhibition space in prime area
- Digital brand exposure (email to participants before and after the event)
- Acknowledgement in the final program
- Company recognition in LinkedIn post
- Exclusive hosting opportunity: premier sponsor for conference cocktail
Gold
Sponsors- Logo featured across all print and digital material
- 1-page ad in symposium print material
- 3 complimentary event registrations
- Logo on sponsors’ recognition banner in registration area
- Exhibition space in prime area
- Digital brand exposure (email to participants before and after the event)
- Acknowledgement in the final program
Silver
Sponsors- Logo featured across all print and digital material
- ½ page ad in symposium print material
- Logo on sponsors’ recognition banner in registration area
- 2 complimentary event registrations
- Exhibition space in prime area
Bronze
Sponsors- Logo featured across all print and digital material
- ½ page ad in symposium print material
- 1 complimentary event registrations
- Logo on sponsors’ recognition banner in registration area
Despite the challenges of developing new therapies for neurological indications, rapid advances in technology are rapidly redefining what is possible in the field and nowhere are these more promising than in neurological diseases.
The Neuro’s Clinical Research Unit (Neuro CRU) is one of Canada’s largest neurological clinical research centres, with over 100 trials per year, and a decade of expertise in early phase and novel therapeutics. Its Platform for Advanced Clinical Therapies allows the unit to fast‑track the development of the most advanced therapeutics — including RNA, gene, and cell therapies — bridging the gap between discovery and treatment.
PLATINUM SPONSORS
